Pushkal Garg - 04 Mar 2026 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg
Issuer symbol
ALNY
Transactions as of
04 Mar 2026
Net transactions value
-$1,524,796
Form type
4
Filing time
06 Mar 2026, 16:13:37 UTC
Previous filing
04 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Garg Pushkal EVP Chief R&D 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg 06 Mar 2026 0001829252

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Sale $33,817 -106 -0.45% $319.03 23,300 04 Mar 2026 Direct F1, F2
transaction ALNY Common Stock Sale $32,641 -102 -0.44% $320.01 23,198 04 Mar 2026 Direct F1, F3
transaction ALNY Common Stock Sale $68,974 -215 -0.93% $320.81 22,983 04 Mar 2026 Direct F1, F4
transaction ALNY Common Stock Sale $93,006 -289 -1.3% $321.82 22,694 04 Mar 2026 Direct F1, F5
transaction ALNY Common Stock Sale $113,054 -350 -1.5% $323.01 22,344 04 Mar 2026 Direct F1, F6
transaction ALNY Common Stock Sale $248,385 -767 -3.4% $323.84 21,577 04 Mar 2026 Direct F1, F7
transaction ALNY Common Stock Sale $88,367 -272 -1.3% $324.88 21,305 04 Mar 2026 Direct F1, F8
transaction ALNY Common Stock Sale $67,739 -208 -0.98% $325.67 21,097 04 Mar 2026 Direct F1, F9
transaction ALNY Common Stock Sale $210,804 -654 -3.1% $322.33 20,443 05 Mar 2026 Direct F10, F11
transaction ALNY Common Stock Sale $239,427 -740 -3.6% $323.55 19,703 05 Mar 2026 Direct F10, F12
transaction ALNY Common Stock Sale $165,541 -510 -2.6% $324.59 19,193 05 Mar 2026 Direct F10, F13
transaction ALNY Common Stock Sale $163,040 -500 -2.6% $326.08 18,693 05 Mar 2026 Direct F10, F14
holding ALNY Common Stock 431 04 Mar 2026 by Managed Account F15
holding ALNY Common Stock 250 04 Mar 2026 by Trust F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations upon the vesting of restricted stock units.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $318.27 to $319.27. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $319.28 to $320.28. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $320.33 to $321.33. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $321.34 to $322.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $322.36 to $323.36. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.38 to $324.35. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.39 to $325.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.40 to $326.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 20, 2025.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $322.03 to $322.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.09 to $324.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.26 to $325.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F14 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.67 to $326.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F15 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F16 Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.